Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

BACKGROUND: Malignant pleural mesothelioma is almost always fatal, and few treatment options are available. Although active symptom control (ASC) has been recommended for the management of this disease, no consensus exists for the role of chemotherapy. We investigated whether the addition of chemoth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Muers, Martin F, Stephens, Richard J, Fisher, Patricia, Darlison, Liz, Higgs, Christopher MB, Lowry, Erica, Nicholson, Andrew G, O'Brien, Mary, Peake, Michael, Rudd, Robin, Snee, Michael, Steele, Jeremy, Girling, David J, Nankivell, Matthew, Pugh, Cheryl, Parmar, Mahesh KB
Format: Artigo
Idioma:Inglês
Publicat: Lancet Publishing Group 2008
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2431123/
https://ncbi.nlm.nih.gov/pubmed/18486741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(08)60727-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars